A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index


About Adolor:

Adolor Corporation is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products.

The goal of the company's research effort is to develop products which maintain or improve opioid-like pain relief while reducing or eliminating opioid side effects.

Research and Development



Entereg™ (alvimopan), is Adolor's lead product candidate Entereg is a synthetic chemical compound that selectively blocks the interaction of narcotic analgesics at peripheral mu opioid receptors without blocking the centrally-mediated analgesic effects.

Adolor's second product candidate is a sterile lidocaine patch in clinical development for the management of postoperative incisional pain.

Preclinical Trials:

Opoid receptor pain targets and cannabinoid receptor pain targets

More on Adolor:

Home Page for Adolor

Key Statistics for Adolor

Basic Chart for Adolor

Analyst Opinion

Analysts Estimates

Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.